- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 333/24 - Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Patent holdings for IPC class C07D 333/24
Total number of patents in this class: 458
10-year publication summary
|
37
|
29
|
37
|
22
|
32
|
19
|
28
|
18
|
15
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allergan, Inc. | 2434 |
10 |
| Janssen Pharmaceutica N.V. | 3611 |
8 |
| Bayer Cropscience AG | 2136 |
8 |
| Alcon, Inc. | 5183 |
7 |
| Piramal Enterprises Limited | 157 |
7 |
| The Salk Institute for Biological Studies | 449 |
7 |
| The Regents of the University of California | 19544 |
6 |
| Sumitomo Chemical Company, Limited | 8987 |
6 |
| Toyama Chemical Co., Ltd. | 108 |
6 |
| Vectus Biosystems Limited | 35 |
6 |
| The General Hospital Corporation | 4651 |
5 |
| Agios Pharmaceuticals, Inc | 211 |
5 |
| BELLUS Health Inc. | 17 |
5 |
| The Broad Institute, Inc. | 1716 |
5 |
| King Abdulaziz University | 505 |
5 |
| Mitobridge, Inc. | 37 |
5 |
| Samsung Electronics Co., Ltd. | 139302 |
4 |
| F. Hoffmann-La Roche AG | 7951 |
4 |
| Massachusetts Institute of Technology | 9921 |
4 |
| Duke University | 3012 |
4 |
| Other owners | 341 |